Denali Therapeutics Inc.
PROGRANULIN VARIANTS

Last updated:

Abstract:

Provided herein are progranulin variants and fusion proteins that comprise a progranulin variant and an Fc polypeptide. Methods of using such proteins to treat progranulin-associated disorders (e.g., a neurodegenerative disease, such as frontotemporal dementia (FTD)) are also provided herein.

Status:
Application
Type:

Utility

Filling date:

17 Mar 2022

Issue date:

7 Jul 2022